SG10201609030SA - Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof - Google Patents

Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof

Info

Publication number
SG10201609030SA
SG10201609030SA SG10201609030SA SG10201609030SA SG10201609030SA SG 10201609030S A SG10201609030S A SG 10201609030SA SG 10201609030S A SG10201609030S A SG 10201609030SA SG 10201609030S A SG10201609030S A SG 10201609030SA SG 10201609030S A SG10201609030S A SG 10201609030SA
Authority
SG
Singapore
Prior art keywords
systemically
methods
active agents
veterinary compositions
oral veterinary
Prior art date
Application number
SG10201609030SA
Other languages
English (en)
Inventor
Mark D Soll
Diane Larsen
Susan Mancini Cady
Peter Cheifetz
Izabela Galeska
Saijun Gong
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47684067&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201609030S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial Inc filed Critical Merial Inc
Publication of SG10201609030SA publication Critical patent/SG10201609030SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068Rumen, e.g. rumen bolus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • A61P33/12Schistosomicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG10201609030SA 2012-02-06 2013-01-31 Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof SG10201609030SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261595463P 2012-02-06 2012-02-06

Publications (1)

Publication Number Publication Date
SG10201609030SA true SG10201609030SA (en) 2016-12-29

Family

ID=47684067

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201609030SA SG10201609030SA (en) 2012-02-06 2013-01-31 Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
SG11201404595TA SG11201404595TA (en) 2012-02-06 2013-01-31 Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201404595TA SG11201404595TA (en) 2012-02-06 2013-01-31 Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof

Country Status (52)

Country Link
US (7) US9233100B2 (enrdf_load_stackoverflow)
EP (4) EP2811998B1 (enrdf_load_stackoverflow)
KR (3) KR102030338B1 (enrdf_load_stackoverflow)
CN (3) CN104168900A (enrdf_load_stackoverflow)
AP (1) AP2014007874A0 (enrdf_load_stackoverflow)
AR (3) AR089910A1 (enrdf_load_stackoverflow)
AU (4) AU2013217633B2 (enrdf_load_stackoverflow)
BR (2) BR122020022192B1 (enrdf_load_stackoverflow)
CA (3) CA2863498C (enrdf_load_stackoverflow)
CL (3) CL2014002087A1 (enrdf_load_stackoverflow)
CO (1) CO7061080A2 (enrdf_load_stackoverflow)
CR (1) CR20140369A (enrdf_load_stackoverflow)
CY (3) CY1121800T1 (enrdf_load_stackoverflow)
CZ (1) CZ308507B6 (enrdf_load_stackoverflow)
DE (1) DE112013000869T5 (enrdf_load_stackoverflow)
DK (5) DK2811998T3 (enrdf_load_stackoverflow)
DO (2) DOP2014000181A (enrdf_load_stackoverflow)
EA (3) EA036899B1 (enrdf_load_stackoverflow)
EC (1) ECSP14016036A (enrdf_load_stackoverflow)
ES (4) ES2882217T3 (enrdf_load_stackoverflow)
FI (1) FI128926B (enrdf_load_stackoverflow)
GB (2) GB2569249C (enrdf_load_stackoverflow)
GE (1) GEP201706772B (enrdf_load_stackoverflow)
GT (1) GT201400172A (enrdf_load_stackoverflow)
HR (4) HRP20190164T1 (enrdf_load_stackoverflow)
HU (5) HUE041514T2 (enrdf_load_stackoverflow)
IL (2) IL233888A (enrdf_load_stackoverflow)
LT (3) LT3216448T (enrdf_load_stackoverflow)
MA (1) MA35923B1 (enrdf_load_stackoverflow)
MD (3) MD4577C1 (enrdf_load_stackoverflow)
ME (2) ME03389B (enrdf_load_stackoverflow)
MX (2) MX351702B (enrdf_load_stackoverflow)
MY (1) MY167560A (enrdf_load_stackoverflow)
NI (3) NI201400841A (enrdf_load_stackoverflow)
NO (2) NO344062B1 (enrdf_load_stackoverflow)
NZ (4) NZ746271A (enrdf_load_stackoverflow)
PE (1) PE20141907A1 (enrdf_load_stackoverflow)
PH (1) PH12014501739B1 (enrdf_load_stackoverflow)
PL (5) PL3216448T3 (enrdf_load_stackoverflow)
PT (5) PT3216448T (enrdf_load_stackoverflow)
RS (3) RS58771B1 (enrdf_load_stackoverflow)
RU (2) RU2763496C2 (enrdf_load_stackoverflow)
SE (2) SE540796C2 (enrdf_load_stackoverflow)
SG (2) SG10201609030SA (enrdf_load_stackoverflow)
SI (3) SI3061454T1 (enrdf_load_stackoverflow)
SM (3) SMT201900312T1 (enrdf_load_stackoverflow)
TN (1) TN2014000336A1 (enrdf_load_stackoverflow)
TR (2) TR201902125T4 (enrdf_load_stackoverflow)
TW (3) TWI641370B (enrdf_load_stackoverflow)
UA (2) UA119843C2 (enrdf_load_stackoverflow)
UY (2) UY39500A (enrdf_load_stackoverflow)
WO (1) WO2013119442A1 (enrdf_load_stackoverflow)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2755473T3 (pl) * 2011-09-12 2019-05-31 Merial Inc Kompozycje przeciwpasożytniczne zawierające izoksazolinową substancję czynną, sposoby i ich zastosowania
CN104168900A (zh) * 2012-02-06 2014-11-26 梅里亚有限公司 包含全身性地起作用的活性剂的杀寄生虫口服兽用组合物、方法及其用途
FI2833866T4 (fi) * 2012-04-04 2025-01-31 Intervet Int Bv Pehmeitä pureskeltavia farmaseuttisia tuotteita
AU2013245478A1 (en) * 2012-11-01 2014-05-15 Sumitomo Chemical Company, Limited Method for administering agent for controlling ectoparasite to dog
US9532946B2 (en) 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units
KR102253847B1 (ko) 2012-12-19 2021-05-21 바이엘 애니멀 헬스 게엠베하 향상된 수용성 및 우수한 저장 안정성을 가지는 정제
AU2014212217B2 (en) 2013-01-31 2016-11-10 Boehringer Ingelheim Animal Health USA Inc. Method for treating and curing Leishmaniosis using fexinidazole
CN105451771B (zh) * 2013-03-15 2020-05-19 阿根塔创新有限公司 可咀嚼配制物
WO2015053636A1 (en) * 2013-10-07 2015-04-16 Harrison Gary Robert Veterinary formulations and methods
PT3063144T (pt) * 2013-11-01 2021-10-28 Boehringer Ingelheim Animal Health Usa Inc Compostos de isoxazolina antiparasitários e pesticidas
EP3079474B1 (en) 2013-12-10 2019-07-03 Intervet International B.V. Antiparasitic use of isoxazoline compounds
EP3236960B1 (en) * 2014-12-22 2025-01-29 Intervet International B.V. Fluralaner for use in the treatment of demodicosis
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
WO2016155815A1 (en) * 2015-04-01 2016-10-06 Ceva Sante Animale Oral solid dosage form of amlodipine and veterinary uses thereof
EA202090762A1 (ru) 2015-04-08 2020-09-08 Мериал, Инк. Инъецируемые препараты замедленного высвобождения, содержащие изоксазолиновое действующее вещество, способы и применение
PL3298027T3 (pl) 2015-05-20 2021-11-08 Boehringer Ingelheim Animal Health USA Inc. Przeciwrobacze związki depsipeptydów
WO2017093986A1 (en) * 2015-12-05 2017-06-08 Canabuzz-Med Veterinary composition and methods for production and use
UY37137A (es) * 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
MD1164Z (ro) * 2016-03-24 2018-02-28 Институт Зоологии Академии Наук Молдовы Compoziţie şi procedeu de alimentare şi deparazitare a fazanilor
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
CA3040278A1 (en) 2016-10-14 2018-04-19 Boehringer Ingelheim Animal Health USA Inc. Pesticidal and parasiticidal vinyl isoxazoline compounds
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
AU2018307726C1 (en) 2017-07-26 2023-03-30 Tgx Soft Chew, Llc Starch-free soft chew for veterinary applications
WO2019036407A1 (en) 2017-08-14 2019-02-21 Merial, Inc. PYRAZOLE-ISOXAZOLINE COMPOUNDS WITH PESTICIDE AND PARASITICIDE ACTIVITY
CN111065380A (zh) 2017-08-17 2020-04-24 法国诗华大药厂 口服组合物及其制备方法
CA3095352A1 (en) 2017-11-23 2019-05-31 Ceva Sante Animale Composition for treating parasites infestations
EP3723483B1 (en) * 2017-12-12 2025-09-03 Intervet International B.V. Implantable fluralaner pharmaceutical compositions and uses thereof
TWI812673B (zh) * 2018-02-12 2023-08-21 美商富曼西公司 用於防治無脊椎害蟲之萘異噁唑啉化合物
KR101881318B1 (ko) * 2018-03-21 2018-07-26 케이엘건설 주식회사 내항균성이 우수한 pet계 수지조성물, 이 pet계 수지조성물이 코팅된 방수/방근 시트, 이 방수/방근 시트를 이용한 방수/방근 공법
CN108669309A (zh) * 2018-05-21 2018-10-19 山东福禾菌业科技有限公司 一种利用食用菌菌渣生产动物饲料的工艺
CA3106092A1 (en) 2018-07-09 2020-01-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anthelminthic heterocyclic compounds
NZ774180A (en) 2018-09-05 2023-04-28 Zoetis Services Llc Palatable antiparasitic formulations
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos
EP3883648A1 (en) 2018-11-20 2021-09-29 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
KR20250112307A (ko) 2019-03-19 2025-07-23 베링거잉겔하임베트메디카게엠베하 구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물
KR102295230B1 (ko) * 2019-06-14 2021-08-30 이종혁 반려동물 구취 억제용 껌과자 및 그 제조방법
US20220323421A1 (en) * 2019-07-22 2022-10-13 Intervet Inc. Soft Chewable Veterinary Dosage Form
KR102166746B1 (ko) 2019-08-27 2020-10-19 민필홍 과산화지질 생성 억제 효과를 가지는 가축 사료용 조성물 및 그의 제조방법
WO2021242481A1 (en) 2020-05-28 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
US11964977B2 (en) 2020-05-29 2024-04-23 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic heterocyclic compounds
KR20230043904A (ko) 2020-07-24 2023-03-31 엘랑코 유에스 인코포레이티드 이속사졸린 화합물 및 이의 중간체의 제조 공정
MX2023007150A (es) 2020-12-18 2023-09-04 Boehringer Ingelheim Animal Health Usa Inc Compuestos de pirazol que contienen boro, composiciones que los comprenden, métodos y usos de los mismos.
EP4262789A1 (en) 2020-12-21 2023-10-25 Boehringer Ingelheim Vetmedica GmbH Parasiticidal collar comprising isoxazoline compounds
EP4304571A4 (en) * 2021-03-11 2025-01-22 In the Bowl Animal Health, Inc. Oral canine feed and methods for controlling flea infestations in a canine
MX2023010378A (es) * 2021-03-11 2024-01-24 In The Bowl Animal Health Inc Alimento canino oral y metodos para controlar infestaciones de garrapatas en un canino.
CN117377477A (zh) * 2021-03-11 2024-01-09 碗中动物健康公司 用于控制哺乳动物中蜱侵袭的饲料和方法
EP4426699A1 (en) 2021-11-01 2024-09-11 Boehringer Ingelheim Vetmedica GmbH Anthelmintic pyrrolopyridazine compounds
EP4447702A2 (en) * 2021-12-17 2024-10-23 Kemin Industries, Inc. Compositions containing organic acids and their esters to prevent mold contamination in animal feed
WO2023126969A1 (en) * 2021-12-30 2023-07-06 Laurus Labs Limited Oral films of anit-parasitic drugs
WO2023198476A1 (en) 2022-04-15 2023-10-19 Krka, D.D., Novo Mesto Soft chewable veterinary dosage form
WO2024007014A2 (en) * 2022-06-30 2024-01-04 Board Of Trustees Of The University Of Arkansas Process for treating livestock exposed to toxic forage using melatonin compositions
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication
WO2025034192A1 (en) 2023-08-07 2025-02-13 Yuriy Synytsya A water-soluble afoxolaner complex, a method for producing thereof and veterinary antiparasitic drugs comprising the same

Family Cites Families (203)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3486186A (en) 1967-05-08 1969-12-30 Hollymatic Corp Molding apparatus
NL160809C (nl) 1970-05-15 1979-12-17 Duphar Int Res Werkwijze ter bereiding van benzoylureumverbindingen, alsmede werkwijze ter bereiding van insekticide prepara- ten op basis van benzoylureumverbindingen.
US3887964A (en) 1972-01-24 1975-06-10 Formax Inc Food patty molding machine
JPS4914624A (enrdf_load_stackoverflow) 1972-06-08 1974-02-08
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US3818047A (en) 1972-08-07 1974-06-18 C Henrick Substituted pyrones
US3952478A (en) 1974-10-10 1976-04-27 Formax, Inc. Vacuum sheet applicator
US4054967A (en) 1975-10-20 1977-10-25 Formax, Inc. Food patty molding machine
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
CH604517A5 (enrdf_load_stackoverflow) 1976-08-19 1978-09-15 Ciba Geigy Ag
US4284652A (en) 1977-01-24 1981-08-18 The Quaker Oats Company Matrix, product therewith, and process
US4134973A (en) 1977-04-11 1979-01-16 Merck & Co., Inc. Carbohydrate derivatives of milbemycin and processes therefor
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4144352A (en) 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4182003A (en) 1978-02-28 1980-01-08 Formax, Inc. Food patty molding machine
US4203976A (en) 1978-08-02 1980-05-20 Merck & Co., Inc. Sugar derivatives of C-076 compounds
US4338702A (en) 1979-03-29 1982-07-13 Holly Harry H Apparatus for making a ground food patty
US4334339A (en) 1980-05-12 1982-06-15 Hollymatic Corporation Mold device with movable compression insert
US4356595A (en) 1980-11-07 1982-11-02 Formax, Inc. Method and apparatus for molding food patties
US4327076A (en) 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4343068A (en) 1981-01-19 1982-08-10 Holly James A Method and apparatus for unidirectional formation of a plug-formed patty with cleanout feature
JPS57139012A (en) 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
US4372008A (en) 1981-04-23 1983-02-08 Formax, Inc. Food patty molding machine with multi-orifice fill passage and stripper plate
US4393085A (en) 1981-08-13 1983-07-12 General Foods Corporation Enzyme digestion for a dog food of improved palatability
IE53474B1 (en) 1981-09-17 1988-11-23 Warner Lambert Co A chewable comestible product and process for its production
CH657506A5 (de) 1981-12-10 1986-09-15 Hollymatic Ag Portioniermaschine zum fuellen von hohlraeumen mit verformbarem material und verwendung derselben.
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US4535505A (en) 1982-11-23 1985-08-20 Holly Systems, Inc. Method and apparatus for forming a patty to accommodate tissue fiber flow
US4608731A (en) 1983-01-11 1986-09-02 Holly Systems, Inc. Food patty with improved void structure, shape, and strength and method and apparatus for forming said patty
JPS59199673A (ja) 1983-04-25 1984-11-12 Sumitomo Chem Co Ltd 含窒素複素環化合物、その製造法およびそれを有効成分とする有害生物防除剤
US4609543A (en) 1983-11-14 1986-09-02 Nabisco Brands, Inc. Soft homogeneous antacid tablet
US4523520A (en) 1984-01-17 1985-06-18 North Side Packing Company Meat processing equipment
US4597135A (en) 1984-02-21 1986-07-01 Holly Systems, Inc. Food patty forming method and apparatus employing two or more agitator bars
EP0179022B1 (de) 1984-10-18 1990-11-07 Ciba-Geigy Ag Benzoylphenylharnstoffe
DE3681465D1 (enrdf_load_stackoverflow) 1985-02-04 1991-10-24 Nihon Bayer Agrochem K.K., Tokio/Tokyo, Jp
EP0237482A1 (de) 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
AR243191A1 (es) 1986-03-25 1993-07-30 Sankyo Co Procedimiento para preparar compuestos de macrolida
US4768941A (en) 1986-06-16 1988-09-06 Hollymatic Corporation Food patty and machine and method for making thereof
DE3778768D1 (de) 1986-07-02 1992-06-11 Ciba Geigy Ag Pestizide.
US4697308A (en) 1986-10-29 1987-10-06 Formax, Inc. Patty molding mechanism for whole fiber food product
DE3636882C1 (de) 1986-10-30 1988-05-19 Schreiber Berthold Vorrichtung zur feinblasigen Einleitung eines Gases in eine Fluessigkeit
US4714620A (en) 1986-12-12 1987-12-22 Warner-Lambert Company Soft, sugarless aerated confectionery composition
US4780931A (en) 1987-02-13 1988-11-01 Marlen Research Corporation Feeding device for patty forming machine
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
DE3888936T2 (de) 1987-11-03 1994-07-21 Beecham Group Plc Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung.
US4821376A (en) 1988-06-02 1989-04-18 Formax, Inc. Seal-off for food patty molding machine with multi-orifice fill passage and stripper plate
US4997671A (en) 1988-09-09 1991-03-05 Nabisco Brands, Inc. Chewy dog snacks
US4872241A (en) 1988-10-31 1989-10-10 Formax, Inc. Patty molding mechanism for fibrous food product
US4935243A (en) 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
OA09249A (fr) 1988-12-19 1992-06-30 Lilly Co Eli Composés de macrolides.
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
US5021025A (en) 1989-09-12 1991-06-04 Wagner Richard C Method and machine for making food patties
US4975039A (en) 1989-09-18 1990-12-04 Dare Gary L Food molding and portioning apparatus
IE904606A1 (en) 1989-12-21 1991-07-03 Beecham Group Plc Novel products
US4996743A (en) 1990-01-29 1991-03-05 Formax, Inc. Mold plate drive linkage
US5022888A (en) 1990-05-03 1991-06-11 Formax, Inc. Co-forming apparatus for food patty molding machine
US5262167A (en) 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
NZ247278A (en) 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
US5380535A (en) 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
WO1992022555A1 (en) 1991-06-17 1992-12-23 Beecham Group Plc Paraherquamide derivatives, precursor thereof, processes for their preparation, microorganism used and their use as antiparasitic agents
JP2575325B2 (ja) 1991-06-18 1997-01-22 サクマ製菓株式会社 キャンディ
US5165218A (en) 1991-06-20 1992-11-24 Callahan Jr Bernard C Automatic sorting, stacking and packaging apparatus and method
US5202242A (en) 1991-11-08 1993-04-13 Dowelanco A83543 compounds and processes for production thereof
US5439924A (en) 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
US5345377A (en) 1992-10-30 1994-09-06 Electric Power Research Institute, Inc. Harmonic controller for an active power line conditioner
US5591606A (en) 1992-11-06 1997-01-07 Dowelanco Process for the production of A83543 compounds with Saccharopolyspora spinosa
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
DK0688332T3 (da) 1993-03-12 1997-10-13 Dowelanco Nye A83543-forbindelser og fremgangsmåder til fremstilling heraf.
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
US5750548A (en) 1994-01-24 1998-05-12 Novartis Corp. 1- N-(halo-3-pyridylmethyl)!-N-methylamino-1-alklamino-2-nitroethylene derivatives for controlling fleas in domestic animals
US5605889A (en) 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
PL185332B1 (pl) 1994-05-20 2003-04-30 Janssen Pharmaceutica Nv Kompozycja przeciwrobacza dla zwierząt towarzyszących człowiekowi zawierająca flubendazol
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US5637313A (en) 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
GB9508443D0 (en) 1995-04-26 1995-06-14 Gilbertson & Page Biscuit for working racing or sporting dogs
AUPN290395A0 (en) 1995-05-10 1995-06-01 Virbac (Australia) Pty Limited Canine anthelmintic preparation
US5578336A (en) 1995-06-07 1996-11-26 Monte; Woodrow C. Confection carrier for vitamins, enzymes, phytochemicals and ailmentary vegetable compositions and method of making
PE10898A1 (es) 1995-06-13 1998-03-20 American Home Prod Formulaciones orales de etodolac s (+)-
TW334436B (en) 1995-07-21 1998-06-21 Upjohn Co Antiparasitic marcfortines and paraherquamides
IE80657B1 (en) 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
US5885607A (en) 1996-03-29 1999-03-23 Rhone Merieux N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs
US6010710A (en) 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
FR2752525B1 (fr) 1996-08-20 2000-05-05 Rhone Merieux Procede de lutte contre les myiases des cheptels bovins et ovins et compositions pour la mise en oeuvre de ce procede
US5735603A (en) 1996-05-03 1998-04-07 Littleford Day, Inc. Horizontal mixer apparatus and method with improved shaft and seal structure
US6001981A (en) 1996-06-13 1999-12-14 Dow Agrosciences Llc Synthetic modification of Spinosyn compounds
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US5730650A (en) 1996-08-29 1998-03-24 Progressive Technology Of Wisconsin, Inc. Food patty molding machine
US5655436A (en) 1996-08-29 1997-08-12 Progressive Technology Of Manitowoc, Inc. Food patty molding machine
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
US6110521A (en) 1996-10-25 2000-08-29 T.F.H. Publications, Inc. Wheat and casein dog chew with modifiable texture
US5827565A (en) 1996-10-25 1998-10-27 T.F.H. Publications, Inc. Process for making an edible dog chew
US6093427A (en) 1997-09-03 2000-07-25 T.F.H.Publications, Inc. Vegetable-based dog chew
US6086940A (en) 1996-10-25 2000-07-11 T.F.H. Publications, Inc. High starch content dog chew
US5753255A (en) 1997-02-11 1998-05-19 Chavkin; Leonard Chewable molded tablet containing medicinally active substances
US6207647B1 (en) 1997-07-18 2001-03-27 Smithkline Beecham Corporation RatA
EP1065936B1 (en) 1998-03-23 2009-08-05 General Mills, Inc. Encapsulation of components into edible products
US6093441A (en) 1998-07-15 2000-07-25 Tfh Publications, Inc. Heat modifiable peanut dog chew
US6270790B1 (en) 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6387381B2 (en) 1998-09-24 2002-05-14 Ez-Med Company Semi-moist oral delivery system
US6060078A (en) 1998-09-28 2000-05-09 Sae Han Pharm Co., Ltd. Chewable tablet and process for preparation thereof
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
US6159516A (en) 1999-01-08 2000-12-12 Tfh Publication, Inc. Method of molding edible starch
GB9902073D0 (en) 1999-01-29 1999-03-24 Nestle Sa Chewy confectionery product
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1171100B1 (en) * 1999-04-13 2003-07-30 Leo Pharma A/S Solubilized pharmaceutical composition for parenteral administration
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
PE20011289A1 (es) 2000-04-07 2001-12-21 Upjohn Co Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
US6399786B1 (en) 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
CA2435761C (en) 2001-01-31 2011-08-30 Bayer Cropscience Gmbh Herbicide-safener combination based on isoxazoline carboxylate safeners
EP1247456A3 (en) 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
GB0108485D0 (en) 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US6893652B2 (en) * 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
WO2003030653A2 (en) 2001-10-05 2003-04-17 Rubicon Scientific Llc Animal feeds including actives and methods of using same
BRPI0313402B1 (pt) 2002-08-13 2018-01-30 Intervet International B.V. Composição farmacêutica veterinária comestível e deglutível na forma de um produto mastigável de dose única e processo para a sua preparação mascar macia, e, processos para produzir a composição
US20040037869A1 (en) 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
TW200409760A (en) 2002-09-11 2004-06-16 Novartis Ag Organic compounds
US20040234579A1 (en) 2003-05-22 2004-11-25 Mark D. Finke, Inc. Dietary supplements and methods of preparing and administering dietary supplements
TWI366442B (en) 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
AU2008201605B2 (en) 2003-07-30 2010-04-29 Novartis Ag Palatable ductile chewable veterinary composition
WO2005016356A1 (en) 2003-08-08 2005-02-24 The Hartz Mountain Corporation Improved anthelmintic formulations
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
HRP20141241T1 (hr) 2004-03-05 2015-02-13 Nissan Chemical Industries, Ltd. Spoj benzamida supstituiran izoksazolinom i sredstvo za suzbijanje štetnih organizama
JP2007532571A (ja) * 2004-04-07 2007-11-15 インターベツト・インターナシヨナル・ベー・ベー ベンズイミダゾール、アベルメクチンおよびプラジカンテルの有効組成物および関連する使用方法
US20050234119A1 (en) 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
CN101098827B (zh) 2004-11-11 2011-06-15 巴塞尔聚烯烃意大利有限责任公司 由含有钛化合物的废液制备TiO2粉末的方法
US7348027B2 (en) 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
BRPI0617076B1 (pt) 2005-09-02 2021-07-06 Nissan Chemical Corporation Composto benzamida substituída por isoxazolina da fórmula (1) ou sal do mesmo; composto benzamida substituido por 4-hidroxiiminametila da fórmula (2) ou sal do mesmo; pesticida; agente agroquímico; parasiticida interno ou externo para mamíferos ou aves; inseticida ou acaricida
US20070128251A1 (en) 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US7955632B2 (en) 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
WO2007070606A2 (en) 2005-12-14 2007-06-21 E. I. Du Pont De Nemours And Company Isoxazolines for controlling invertebrate pests
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
ATE466846T1 (de) 2006-03-10 2010-05-15 Nissan Chemical Ind Ltd Substituierte isoxazolin-verbindung und schädlingsbekämpfungsmittel
MX2008013307A (es) 2006-04-20 2008-10-27 Du Pont Pirazolinas para controlar plagas de invertebrados.
WO2007125984A1 (ja) 2006-04-28 2007-11-08 Nihon Nohyaku Co., Ltd. イソキサゾリン誘導体及び有害生物防除剤並びにその使用方法
CA2656617C (en) 2006-07-05 2014-10-14 Aventis Agriculture 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
JP2008044880A (ja) 2006-08-15 2008-02-28 Bayer Cropscience Ag 殺虫性イソオキサゾリン類
AU2007293068C1 (en) 2006-09-07 2013-09-19 Boehringer Ingelheim Animal Health USA Inc. Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations
US8119671B2 (en) 2007-03-07 2012-02-21 Nissan Chemical Industries, Ltd. Isoxazoline-substituted benzamide compound and pest control agent
WO2008114493A1 (ja) 2007-03-16 2008-09-25 Kumiai Chemical Industry Co., Ltd. 除草剤組成物
JP5256753B2 (ja) 2007-03-29 2013-08-07 住友化学株式会社 イソオキサゾリン化合物とその有害生物防除用途
MY146638A (en) 2007-04-10 2012-09-14 Bayer Cropscience Ag Insecticidal aryl isoxazoline derivatives
BRPI0721629B1 (pt) 2007-05-03 2019-03-19 Merial, Inc. Composições compreendendo compostos macrolídeos com éter de alquila em c-13 e compostos de fenilpirazol
AU2008247327B2 (en) 2007-05-07 2013-08-22 Jurox Pty Ltd Improved dosage form and process
ES2549377T3 (es) 2007-05-15 2015-10-27 Merial, Inc. Compuestos de ariloazol-2-il cianoetilamino, procedimiento de fabricación y procedimiento de utilización de los mismos
US20080293645A1 (en) * 2007-05-25 2008-11-27 Schneider Lawrence F Antiparasitic combination and method for treating domestic animals
EP2155701B1 (en) 2007-06-13 2013-12-11 E. I. Du Pont de Nemours and Company Isoxazoline insecticides
EP2171450B1 (en) 2007-06-22 2012-03-21 GENERA ISTRAZIVANJA d.o.o. Adamts4 as a blood biomarker and therapeutic target for chronic renal failure
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
WO2009001942A1 (ja) 2007-06-27 2008-12-31 Nissan Chemical Industries, Ltd. 3-ヒドロキシプロパン-1-オン化合物、2-プロペン-1-オン化合物およびイソキサゾリン化合物の製造方法
EP2172448A4 (en) 2007-06-29 2012-01-11 Nissan Chemical Ind Ltd SUBSTITUTED ISOXAZOLINE OR ENONOXINE COMPOUND AND PESTICIDES
DK2170321T3 (da) 2007-06-29 2013-07-29 Zoetis Llc Ormekur-kombination
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
WO2009035004A1 (ja) 2007-09-10 2009-03-19 Nissan Chemical Industries, Ltd. 置換イソキサゾリン化合物および有害生物防除剤
EP2193124B1 (en) 2007-10-03 2012-12-19 E. I. du Pont de Nemours and Company Naphthalene isoxazoline compounds for control of invertebrate pests
EP2317856A1 (en) * 2008-07-09 2011-05-11 Basf Se Pesticidal mixtures comprising isoxazoline compounds ii
CA2973871C (en) 2008-07-09 2019-09-10 Nissan Chemical Industries, Ltd. Production method of isoxazoline-substituted benzoic acid amide compound
JP2011527307A (ja) 2008-07-09 2011-10-27 ビーエーエスエフ ソシエタス・ヨーロピア イソオキサゾリン化合物iを含む殺有害生物活性混合物
EP2331535B1 (en) 2008-09-04 2015-07-22 Syngenta Participations AG Insecticidal compounds
KR101782308B1 (ko) 2008-10-21 2017-09-27 메리얼 인코포레이티드 티오아미드 화합물, 이의 제조 방법 및 사용 방법
EA019606B1 (ru) 2008-11-14 2014-04-30 Мериал Лимитед Арилоазол-2-илцианоэтиламино соединения противопаразитарного действия, обогащенные одним из энантиомеров
US8377942B2 (en) 2008-12-18 2013-02-19 Novartis Ag Isoxazolines derivatives and their use as pesticide
CN102256971B (zh) 2008-12-19 2014-09-17 诺华股份有限公司 作为杀虫剂的异噁唑啉衍生物及其用途
CA2747986A1 (en) 2008-12-23 2010-07-01 Basf Se Substituted amidine compounds for combating animal pests
WO2010084067A2 (en) 2009-01-22 2010-07-29 Syngenta Participations Ag Insecticidal compounds
WO2010108733A1 (en) 2009-03-26 2010-09-30 Syngenta Participations Ag Insecticidal compounds
EP2414353A1 (en) 2009-04-01 2012-02-08 Basf Se Isoxazoline compounds for combating invertebrate pests
US9029639B2 (en) * 2009-07-06 2015-05-12 Basf Se Pyridazine compounds for controlling invertebrate pests
TWI487486B (zh) 2009-12-01 2015-06-11 Syngenta Participations Ag 以異唑啉衍生物為主之殺蟲化合物
KR101826977B1 (ko) 2009-12-17 2018-02-07 메리얼 인코포레이티드 구충성 디히드로아졸 화합물 및 이를 함유하는 조성물
US8999889B2 (en) 2010-02-01 2015-04-07 Basf Se Substituted ketonic isoxazoline compounds and derivatives for combating animal pests
KR20120133401A (ko) 2010-02-25 2012-12-10 신젠타 리미티드 이속사졸린 유도체의 제조 방법
WO2011104088A1 (en) 2010-02-25 2011-09-01 Syngenta Participations Ag Pesticidal mixtures containing isoxazoline derivatives and a fungicide
AU2011220039B2 (en) 2010-02-25 2014-01-16 Syngenta Limited Pesticidal mixtures containing isoxazoline derivatives and insecticide or nematoicidal biological agent
WO2011124998A1 (en) 2010-04-08 2011-10-13 Pfizer Inc. Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides
ES2566402T3 (es) * 2010-05-27 2016-04-12 E. I. Du Pont De Nemours And Company Forma cristalina de 4-[5-[3-cloro-5-(trifluorometil)fenil]-4,5-dihidro-5-(trifluorometil)-3-isoxazolil]-N-[2-oxo-2-[(2,2,2-trifluoroetil)amino]etil]-1-naftalenocarboxamida
BR112012031088A8 (pt) 2010-06-09 2017-10-10 Syngenta Participations Ag Misturas pesticidas incluindo os derivados da isoxazolina
WO2011154434A2 (en) 2010-06-09 2011-12-15 Syngenta Participations Ag Pesticidal mixtures including isoxazoline derivatives
BR112012031277A2 (pt) 2010-06-09 2016-09-27 Syngenta Participations Ag "misturas pesticidas compreendendo derivados de isoxazolina"
UY33403A (es) 2010-06-17 2011-12-30 Novartis Ag Compuestos orgánicos con novedosas isoxazolinas, sus n-óxidos, s-óxidos y sales
DK178277B1 (da) 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
WO2012007426A1 (en) 2010-07-13 2012-01-19 Basf Se Azoline substituted isoxazoline benzamide compounds for combating animal pests
EP2601190B1 (en) 2010-08-05 2018-07-04 Zoetis Services LLC Isoxazoline derivatives as antiparasitic agents
AU2011306489B2 (en) 2010-09-24 2015-11-05 Zoetis Services Llc Isoxazoline oximes as antiparasitic agents
ES2806256T3 (es) 2010-10-12 2021-02-17 Bayer Ip Gmbh Productos masticables blandos no basados en almidón
WO2012086462A1 (ja) 2010-12-20 2012-06-28 日本曹達株式会社 イソオキサゾリン化合物および有害生物防除剤
PT2658542T (pt) 2010-12-27 2022-03-10 Intervet Int Bv Formulação de isoxazolina localizada tópica
CA2822853C (en) 2010-12-27 2021-05-11 Intervet International B.V. Topical localized isoxazoline formulation comprising glycofurol
EP2673273A1 (en) 2011-02-10 2013-12-18 Novartis AG Isoxazoline derivatives for controlling invertebrate pests
AR085657A1 (es) 2011-03-10 2013-10-16 Novartis Ag Compuestos de isoxazol
ME02412B (me) 2011-03-10 2016-09-20 Zoetis Services Llc Spirociklični derivati izoksazolina kao antiparazitska sredstva
PL2755473T3 (pl) * 2011-09-12 2019-05-31 Merial Inc Kompozycje przeciwpasożytniczne zawierające izoksazolinową substancję czynną, sposoby i ich zastosowania
CN104168900A (zh) 2012-02-06 2014-11-26 梅里亚有限公司 包含全身性地起作用的活性剂的杀寄生虫口服兽用组合物、方法及其用途
FI2833866T4 (fi) 2012-04-04 2025-01-31 Intervet Int Bv Pehmeitä pureskeltavia farmaseuttisia tuotteita
US9532946B2 (en) 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units

Also Published As

Publication number Publication date
HUE054367T2 (hu) 2021-09-28
DK3216448T3 (da) 2019-05-20
EA201400878A1 (ru) 2014-12-30
ES2743673T3 (es) 2020-02-20
EP3061454A1 (en) 2016-08-31
RU2018121905A3 (enrdf_load_stackoverflow) 2020-09-11
US10596156B2 (en) 2020-03-24
PL230178B1 (pl) 2018-09-28
NI201400841A (es) 2014-10-24
RS58370B1 (sr) 2019-03-29
NZ746271A (en) 2020-05-29
SI2811998T1 (sl) 2019-02-28
LT2811998T (lt) 2019-02-25
UY39500A (es) 2021-12-31
MD20140093A2 (ro) 2015-02-28
GEP201706772B (en) 2017-11-27
PT2811998T (pt) 2019-02-21
ES2882217T3 (es) 2021-12-01
NZ628144A (en) 2016-09-30
CA2966703A1 (en) 2013-08-15
NO344062B1 (no) 2019-08-26
WO2013119442A1 (en) 2013-08-15
US20130203692A1 (en) 2013-08-08
GB2569249A (en) 2019-06-12
SE1450995A1 (sv) 2014-08-27
DOP2014000181A (es) 2015-02-27
TWI707679B (zh) 2020-10-21
DK179451B1 (da) 2018-10-17
GB201903924D0 (en) 2019-05-08
DE112013000869T5 (de) 2014-10-16
CA3094706A1 (en) 2013-08-15
MX2014009429A (es) 2014-11-10
ME03389B (me) 2020-01-20
KR102023225B1 (ko) 2019-11-04
MA35923B1 (fr) 2014-12-01
PT3216448T (pt) 2019-07-08
DK2811998T3 (en) 2019-02-25
AR116415A2 (es) 2021-05-05
HU230959B1 (hu) 2019-06-28
US9931320B2 (en) 2018-04-03
IL251647B (en) 2018-01-31
US20160143285A1 (en) 2016-05-26
HRP20140841B1 (hr) 2022-02-04
GB2514951B (en) 2019-11-06
GB2569249B (en) 2019-11-13
PL2811998T3 (pl) 2019-05-31
NZ719079A (en) 2017-09-29
SE540796C2 (en) 2018-11-13
AU2019200201B2 (en) 2020-10-08
PT2013119442B (pt) 2018-05-04
NI201400084A (es) 2014-10-24
DK201670242A1 (en) 2016-05-02
EA201692257A3 (ru) 2017-08-31
NO345058B1 (no) 2020-09-14
CY1122097T1 (el) 2020-11-25
CY1121800T1 (el) 2020-07-31
CL2014002087A1 (es) 2014-10-10
HUE043949T2 (hu) 2019-09-30
GB2569249C (en) 2021-03-03
UY34617A (es) 2013-09-30
CL2014003509A1 (es) 2015-04-17
ECSP14016036A (es) 2019-01-31
GB2514951C (en) 2020-11-04
PH12014501739A1 (en) 2014-11-10
BR112014019262B1 (pt) 2021-06-22
DK3061454T3 (da) 2021-06-07
NZ731588A (en) 2018-11-30
TN2014000336A1 (en) 2015-12-21
SI3061454T1 (sl) 2021-08-31
MD4577B1 (ro) 2018-07-31
IL233888A0 (en) 2014-09-30
SMT202100261T1 (it) 2021-07-12
NO20141084A1 (no) 2014-09-05
SMT201900312T1 (it) 2019-07-11
EP3216448A1 (en) 2017-09-13
FI20145771A7 (fi) 2014-09-05
HRP20191004T1 (hr) 2019-08-23
TW201731505A (zh) 2017-09-16
PE20141907A1 (es) 2014-12-13
RS58771B1 (sr) 2019-06-28
HRP20190164T1 (hr) 2019-04-05
EP3061454B1 (en) 2021-03-10
AP2014007874A0 (en) 2014-08-31
US20160374994A1 (en) 2016-12-29
ES2720201T3 (es) 2019-07-18
TW201916879A (zh) 2019-05-01
HRP20210649T1 (hr) 2021-05-28
PH12014501739B1 (en) 2014-11-10
PL420160A1 (pl) 2017-09-11
CZ2014606A3 (cs) 2014-10-15
PT109395B (pt) 2020-10-01
KR102030338B1 (ko) 2019-10-10
DK180038B1 (en) 2020-01-30
MD20170009A2 (ro) 2017-07-31
AU2019200201B9 (en) 2021-02-18
MD20170008A2 (ro) 2017-07-31
US9233100B2 (en) 2016-01-12
ES2515015R1 (es) 2015-01-23
AU2017200362B2 (en) 2018-10-18
SG11201404595TA (en) 2014-09-26
EP2811998A1 (en) 2014-12-17
US20190105305A1 (en) 2019-04-11
DOP2018000085A (es) 2018-06-30
TR201909461T4 (tr) 2019-07-22
CN110251509A (zh) 2019-09-20
CN110403937A (zh) 2019-11-05
RU2018121905A (ru) 2019-03-06
TWI641370B (zh) 2018-11-21
UA119843C2 (uk) 2019-08-27
SMT201900083T1 (it) 2019-02-28
US9259417B2 (en) 2016-02-16
CA2863498A1 (en) 2013-08-15
EP2811998B1 (en) 2018-11-14
CO7061080A2 (es) 2014-09-19
CR20140369A (es) 2014-11-05
CA2863498C (en) 2017-10-03
GT201400172A (es) 2017-08-24
TW201336495A (zh) 2013-09-16
MX380711B (es) 2025-03-12
MY167560A (en) 2018-09-14
PL410258A1 (pl) 2015-07-20
IL251647A0 (en) 2017-06-29
KR20190008995A (ko) 2019-01-25
ES2515015B2 (es) 2016-03-01
NO20190907A1 (no) 2013-08-07
DK201470535A (en) 2014-09-03
IL233888A (en) 2017-09-28
CL2018001762A1 (es) 2018-08-24
ES2515015A2 (es) 2014-10-28
HK1199708A1 (en) 2015-07-17
HRP20140841A2 (hr) 2015-06-19
EA201991919A1 (ru) 2020-05-08
UA129512C2 (uk) 2025-05-21
MX2020002188A (es) 2021-03-18
CZ308507B6 (cs) 2020-10-07
PL3216448T3 (pl) 2019-09-30
KR20140129145A (ko) 2014-11-06
AU2013217633B2 (en) 2017-01-12
AU2019200201A1 (en) 2019-01-31
SE1751350A1 (en) 2017-10-31
EA036899B1 (ru) 2021-01-13
MD4577C1 (ro) 2019-02-28
BR122020022192B1 (pt) 2021-12-07
BR112014019262A8 (pt) 2017-07-11
HUP1400439A2 (hu) 2014-12-29
AR124687A2 (es) 2023-04-26
CY1124075T1 (el) 2022-05-27
AU2013217633A1 (en) 2014-08-21
EP3216448B1 (en) 2019-03-27
TWI632910B (zh) 2018-08-21
EA201692257A2 (ru) 2017-06-30
KR20190102084A (ko) 2019-09-02
LT3216448T (lt) 2019-06-10
HU231098B1 (hu) 2020-08-28
EA030398B1 (ru) 2018-07-31
US20150164864A1 (en) 2015-06-18
TR201902125T4 (tr) 2019-03-21
US20200179345A1 (en) 2020-06-11
EP3766491A1 (en) 2021-01-20
RS61949B1 (sr) 2021-07-30
US20180185336A1 (en) 2018-07-05
PL3061454T3 (pl) 2021-09-20
NI201400842A (es) 2014-10-24
PT109395A (pt) 2016-10-03
MX351702B (es) 2017-10-25
SI3216448T1 (sl) 2019-06-28
RU2763496C2 (ru) 2021-12-29
FI128926B (en) 2021-03-15
PL232463B1 (pl) 2019-06-28
PT3061454T (pt) 2021-05-12
CN104168900A (zh) 2014-11-26
GB2514951A (en) 2014-12-10
ME03323B (me) 2019-10-20
LT3061454T (lt) 2021-05-10
SE539857C2 (en) 2017-12-19
HUE041514T2 (hu) 2019-05-28
EP3216448B8 (en) 2019-06-05
FI20145771L (fi) 2014-09-05
GB201415480D0 (en) 2014-10-15
RU2660346C1 (ru) 2018-07-05
AU2020264341A1 (en) 2020-12-03
CA2966703C (en) 2020-12-22
AR089910A1 (es) 2014-10-01
AU2017200362A1 (en) 2017-02-16
BR112014019262A2 (enrdf_load_stackoverflow) 2017-06-20
HK1223023A1 (en) 2017-07-21

Similar Documents

Publication Publication Date Title
GB2514951C (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
IL249141B (en) Preparations for the treatment of parasites containing a large number of active factors, their methods and uses
IL251177B (en) Parasitic preparations containing benzaimidazole history, methods and uses